PT-141 (Bremelanotide)

Sexual HealthResearch Use Only

Also known as: Bremelanotide

PT-141, also known as bremelanotide, is a melanocortin receptor agonist commonly referenced in research literature in relation to sexual arousal pathways in the central nervous system. Unlike vascular-focused approaches, its discussed mechanism involves brain signaling. This content is educational only and is not medical advice.

Typical range (research)

Commonly referenced around 0.5-2 mg per administration in research settings

Half-life

~2-3 hours

Route

Subcutaneous (research)

Common use

Sexual arousal and libido research

Common vial sizes

10 mg

Storage

Store lyophilized powder frozen or refrigerated; reconstituted solution refrigerated at 2-8°C and used within a few weeks.

Reported side effects

NauseaFlushingHeadacheTransient blood pressure changes

Regulatory note: A form of bremelanotide is an approved prescription drug in some jurisdictions; research-grade material is not intended for human use.

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.